Table 2.

Treatment delivered

Treatment features	T‐FAC (n = 58)	FAC‐T (n = 60)
RDI FAC, median (IQR)	98.2 (93.6–100.6)	99.0 (95.8–100.6)
RDI T, median (IQR)	98.5 (96.7–100.4)	97.7 (91.9–100.2)
Dose reduction, n (%)	3 (5)	11 (18)
Dose interruption, n (%)	4 (7)	4 (7)
Blood transfusion, n (%)	1 (2)	2 (3)
GCSF use, n (%)	12 (21)	14 (23)

Abbreviations: FAC, fluorouracil, doxorubicin, and cyclophosphamide; GSCF, granulocyte colony‐stimulating factor; IQR, interquartile range; RDI, relative dose intensity; T, docetaxel.